Expert Panel Hosts Follicular Lymphoma Symposium on September 15
In recognition of World Lymphoma Awareness Day on Saturday 15 September 2012, Rush University Cancer Center, Rush Medical Center, Chicago Blood Cancer Foundation and Hope for Lymphoma are hosting Follicular Lymphoma: On the Road to Cure, a patient and caregiver educational symposium held at Chicago's Searle Conference Center.
This symposium features some of the world's foremost experts on lymphoma. It is free, all you have to do is register.
TOPICS
The symposium's expert panel will discuss a variety of topics, including:
Follicular Lymphoma Basics by Brad S. Kahl MD, Chair of Lymphoma Research at University of Wisconsin Carbone Cancer Center.
Management of Symptomatic, High Tumor Burden, or Bulky Disease by Matthias J. Rummel MD of Justus-Liebig University Hospital and School of Medicine.
Is Watch & Wait Out of Date? by Parameswaran Venugopal, MD of Rush University Medical Center and others.
Latest Options for Relapse by Christopher Flowers MD of Emory University School of Medicine.
Progress in Stem Cell Transplantation by Dr. Flowers along with Henry C. Fung MD and Sunita Nathan MD of Rush University Medical Center.
The Winding Road: Our Journeys to Long Term Survival by author Betsy de Parry, who also hosts the PBS show Candid Cancer.
How Close Are We To Cure? by the Director of the Lymphoma Program at the Abramson Cancer Center of the University of Pennsylvania, Stephen J. Schuster MD. Dr. Schuster will be discussing the role of cancer vaccines such as Biovest's BiovaxID in lymphoma.
Managing Follicular Lymphoma for Long Term Optimal Survivorship by the symposium's panel of experts.
LIVESTREAM
You don't need to be in Chicago to get the most out of this incredible symposium--it will be livestreamed from the symposium's web site beginning at 9 AM central time.
Registration required, but it's still free!
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
